schizandrer a has been researched along with daunorubicin in 1 studies
Studies (schizandrer a) | Trials (schizandrer a) | Recent Studies (post-2010) (schizandrer a) | Studies (daunorubicin) | Trials (daunorubicin) | Recent Studies (post-2010) (daunorubicin) |
---|---|---|---|---|---|
65 | 0 | 52 | 8,239 | 886 | 1,310 |
Protein | Taxonomy | schizandrer a (IC50) | daunorubicin (IC50) |
---|---|---|---|
72 kDa type IV collagenase | Homo sapiens (human) | 1.9 | |
Multidrug resistance-associated protein 1 | Homo sapiens (human) | 8 | |
Histone deacetylase 1 | Homo sapiens (human) | 0.047 | |
Histone deacetylase 8 | Homo sapiens (human) | 0.22 | |
Histone deacetylase 6 | Homo sapiens (human) | 0.02 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hu, X; Lu, Q; Pan, Q; Zhang, K | 1 |
1 other study(ies) available for schizandrer a and daunorubicin
Article | Year |
---|---|
Dibenzocyclooctadiene lingnans: a class of novel inhibitors of P-glycoprotein.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Proliferation; Cyclooctanes; Daunorubicin; Dioxoles; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Inhibitory Concentration 50; K562 Cells; Lignans; Paclitaxel; Polycyclic Compounds; Prohibitins; Vincristine | 2006 |